Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05696405Completed

VATS for Resection of Mediastinal Parathyroids

Role: lead

NCT05067881Completed

Post-COVID-19 Pneumo-hematocele

Role: lead

NCT04859881Completed

Risk Factors for Barotrauma in COVID-19

Role: lead

NCT04484116Completed

IOPTH Usefulness for Predicting Successful Surgery in Secondary Hyperparathyroidism

Role: lead

NCT03345368Not ApplicableCompleted

Effect of rTMS in Combination With a Low-carbohydrate Diet in Patients With Obesity

Role: lead

All 5 trials loaded